ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals is seeking an experienced Senior Scientist to independently lead analytical development and product characterization activities for molecules in CMC development. The role involves developing and optimizing analytical methods, performing sample analysis using various laboratory techniques, and ensuring compliance with company standards. The selected candidate will contribute to the company's mission of bringing new therapies to cancer patients by providing lab support across various projects and teams.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2014
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies that target cancer resistance mechanisms. The company's pipeline includes rinzimetostat and enozertinib, which are being evaluated in clinical trials for cancers such as prostate cancer and non-small cell lung cancer (NSCLC). ORIC's resistance platform addresses innate, acquired, and bypass resistance to improve the efficacy and duration of existing cancer treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ORIC Pharmaceuticals Inc.
33% above the average for this role
Lead Scientist-DP Analytical Development- OSD
Syngene International Limited
Scientist II, Analytical Development
PepGen
Scientist – Analytical Development
Syngene International Limited
Senior Scientist – Analytical Development
Syngene International Limited
Scientist – Analytical Development
Syngene International Limited
Scientist I, Analytical Sciences
WuXi Biologics